\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ patient\\ was\\ referred\\ to\\ pulmonary\\ medicine\\ and\\ eventually\\ to\\ interventional\\ radiology\\ to\\ discuss\\ emobolization\\.\\ feeding\\ vessel\\ diameter\\ measured\\ 3\\ mm\\ and\\ total\\ lesions\\ size\\ was\\ 1\\ cm\\.\\ shunt\\ fraction\\ determined\\ to\\ be\\ 8\\%\\.\\ patient\\ was\\ offered\\ embolization\\ but\\ opted\\ for\\ follow\\ up\\ in\\ 6\\ months\\.\ \(0\)\
\-\ chest\\ x\\-ray\\:\ \(2\)\
\-\ solitary\\ left\\ pulmonary\\ nodule\\.\ \(0\)\
\-\ noncontrast\\ ct\\:\ \(0\)\
\-\ well\\ defined\\,\\ lobular\\ left\\ pulmonary\\ nodule\\ with\\ apparent\\ feeding\\ \\/\\ draining\\ vessel\\.\ \(0\)\
\-\ contrast\\ enhanced\\ ct\\:\\ \ \(0\)\
\-\ prompt\\ pulmonary\\ arterial\\ phase\\ enhancement\\ of\\ well\\ defined\\,\\ lobular\\ left\\ pulmonary\\ nodule\\ with\\ enhancing\\ feeding\\ and\\ draining\\ vessels\\.\ \(0\)\
\-\ pulmonary\\ arteriovenous\\ malformation\ \(5\)\
\-\ pulmonary\\ arteriovenous\\ malformation\ \(5\)\
\-\ cough\\.\ \(59\)\
\-\ pulmonary\\ arteriovenous\\ malformations\\ are\\ abnormal\\ direct\\ connections\\ between\\ the\\ pulmonary\\ arterial\\ and\\ venous\\ systems\\ forming\\ a\\ right\\ to\\ left\\ shunt\\.\\ lesions\\ may\\ be\\ single\\ or\\ multiple\\ and\\ are\\ frequently\\ discovered\\ as\\ solitary\\ pulmonary\\ nodules\\ on\\ chest\\ x\\-ray\\.\\ many\\ are\\ associated\\ with\\ rendu\\-osler\\-weber\\ syndrome\\ and\\ autosomal\\ dominant\\ disorder\\.\\ most\\ often\\ lesions\\ are\\ asymptomatic\\ but\\ they\\ may\\ present\\ with\\ symptoms\\ related\\ to\\ arteriovenous\\ shunting\\.\\ symptoms\\ may\\ include\\ hypoxia\\,\\ dyspnea\\,\\ hemoptysis\\,\\ and\\ possibly\\ from\\ embolic\\ events\\.\\ \ \(0\)\
\-\ on\\ chest\\ x\\-ray\\ finding\\ is\\ usually\\ a\\ pulmonary\\ nodule\\,\\ possibly\\ with\\ a\\ visible\\ feeding\\ vessel\\ extending\\ from\\ the\\ hilum\\.\\ on\\ ct\\,\\ lesions\\ appear\\ somewhat\\ lobulated\\ and\\ well\\ defined\\,\\ also\\ with\\ feeding\\ and\\ draining\\ vessels\\ emanating\\ from\\ and\\ to\\ the\\ hilum\\.\\ the\\ vascular\\ nature\\ of\\ these\\ lesions\\ is\\ well\\ defined\\ with\\ characteristic\\ intravenous\\ contrast\\ enhancement\\.\\ similar\\ findings\\ can\\ also\\ be\\ seen\\ on\\ pulmonary\\ angiography\\.\\ \ \(0\)\
\-\ important\\ radiographic\\ criteria\\ include\\ feeding\\ vessel\\ thickness\\,\\ overall\\ size\\,\\ and\\ shunt\\ fraction\\.\\ lesions\\ are\\ typically\\ recommended\\ for\\ treatment\\ with\\ the\\ feeding\\ vessel\\ is\\ \\>\\ 3\\ mm\\,\\ the\\ lesion\\ is\\ \\>\\ 2\\ cm\\ in\\ size\\,\\ or\\ the\\ shunt\\ fraction\\ is\\ \\>\\ 12\\-15\\ \\%\\.\\ treatment\\ may\\ be\\ surgical\\ or\\ endovascular\\.\\ \ \(0\)\
\-\ treatment\\ is\\ intended\\ to\\ reduce\\ right\\ to\\ left\\ shunting\\ and\\ subsequently\\ to\\ reduce\\ the\\ risk\\ of\\ venous\\ to\\ arterial\\ embolization\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ armstrong\\ p\\.\\ et\\ al\\.\\ imaging\\ of\\ diseases\\ of\\ the\\ chest\\.\\ 3rd\\ edition\\.\\ mosby\\ 2000\\:708\\-711\ \(0\)\
\-\ 2\\.\\ http\\:\\/\\/www\\.amersham\\-health\\.com\\/\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ feeding\\:\\ 0\\.08549557486312616\ \(0\)\
\-\ pulmonary\\:\\ 0\\.08345014964523889\ \(0\)\
\-\ vessel\\:\\ 0\\.05669340244572769\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.04996975023599072\ \(0\)\
\-\ shunt\\:\\ 0\\.04925982472751041\ \(0\)\
\-\ fraction\\:\\ 0\\.04863331044912959\ \(0\)\
\-\ defined\\:\\ 0\\.04011791271707535\ \(0\)\
\-\ nodule\\:\\ 0\\.03924471976871316\ \(0\)\
\-\ lesions\\:\\ 0\\.03823220901967601\ \(0\)\
\-\ draining\\:\\ 0\\.03792912789652181\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.03219504562986009\ \(0\)\
\-\ arterial\\:\\ 0\\.03125636163286355\ \(0\)\
\-\ shunting\\:\\ 0\\.030352215008245257\ \(0\)\
\-\ hilum\\:\\ 0\\.02870170906872898\ \(0\)\
\-\ lobular\\:\\ 0\\.026888770904747766\ \(0\)\
\-\ reduce\\:\\ 0\\.026888770904747766\ \(0\)\
\-\ 2000\\:708\\-711\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ \\/\\/www\\.amersham\\-health\\.com\\/\\:\\ 0\\.02455576162664763\ \(0\)\
\-\ possibly\\:\\ 0\\.024361376977583185\ \(0\)\
\-\ size\\:\\ 0\\.02394046689174461\ \(0\)\
\-\ \\>\\:\\ 0\\.02372563382731391\ \(0\)\
\-\ solitary\\:\\ 0\\.023625668219850227\ \(0\)\
\-\ chest\\:\\ 0\\.022782495822367896\ \(0\)\
\-\ emobolization\\:\\ 0\\.0226249895359514\ \(0\)\
\-\ embolization\\:\\ 0\\.022168448562757775\ \(0\)\
\-\ well\\:\\ 0\\.02153850643976213\ \(0\)\
\-\ rendu\\-osler\\-weber\\:\\ 0\\.02149556026545512\ \(0\)\
\-\ may\\:\\ 0\\.020883881547611408\ \(0\)\
\-\ 12\\-15\\:\\ 0\\.020694217445255174\ \(0\)\
\-\ intended\\:\\ 0\\.020694217445255174\ \(0\)\
\-\ armstrong\\:\\ 0\\.020072647664435648\ \(0\)\
\-\ connections\\:\\ 0\\.019564788174758894\ \(0\)\
\-\ vessels\\:\\ 0\\.019165682541962856\ \(0\)\
\-\ malformation\\:\\ 0\\.018988003635133033\ \(0\)\
\-\ opted\\:\\ 0\\.018435358904262615\ \(0\)\
\-\ emanating\\:\\ 0\\.018435358904262615\ \(0\)\
\-\ mm\\:\\ 0\\.01750526549746521\ \(0\)\
\-\ venous\\:\\ 0\\.017280142721209632\ \(0\)\
\-\ forming\\:\\ 0\\.016353981740390135\ \(0\)\
\-\ are\\:\\ 0\\.016223870090941526\ \(0\)\
\-\ offered\\:\\ 0\\.016211103483043197\ \(0\)\
\-\ events\\:\\ 0\\.01607519773326762\ \(0\)\
\-\ discuss\\:\\ 0\\.015945615517014435\ \(0\)\
\-\ \\:\\:\\ 0\\.01574198908064993\ \(0\)\
\-\ p\\.\\:\\ 0\\.01570324399336644\ \(0\)\
\-\ hypoxia\\:\\ 0\\.015081674212546916\ \(0\)\
\-\ endovascular\\:\\ 0\\.014901901173166494\ \(0\)\
\-\ be\\:\\ 0\\.014682526165391969\ \(0\)\
\-\ prompt\\:\\ 0\\.014652285132248146\ \(0\)\
\-\ embolic\\:\\ 0\\.014497494460507725\ \(0\)\
\-\ treatment\\:\\ 0\\.014453623617834711\ \(0\)\
\-\ interventional\\:\\ 0\\.014280331392346968\ \(0\)\
\-\ edition\\:\\ 0\\.01421154974167741\ \(0\)\
\-\ mosby\\:\\ 0\\.014014843426318209\ \(0\)\
\-\ autosomal\\:\\ 0\\.013772471902670216\ \(0\)\
\-\ hemoptysis\\:\\ 0\\.013715036562272622\ \(0\)\
\-\ include\\:\\ 0\\.013354615532202154\ \(0\)\
\-\ left\\:\\ 0\\.013316229377060094\ \(0\)\
\-\ malformations\\:\\ 0\\.013293780379197626\ \(0\)\
\-\ eventually\\:\\ 0\\.013104859498031161\ \(0\)\
\-\ to\\:\\ 0\\.013085652347835233\ \(0\)\
\-\ criteria\\:\\ 0\\.013014996372075113\ \(0\)\
\-\ measured\\:\\ 0\\.012927941933345016\ \(0\)\
\-\ cm\\:\\ 0\\.012768557759426105\ \(0\)\
\-\ enhancement\\:\\ 0\\.012760383098178474\ \(0\)\
\-\ noncontrast\\:\\ 0\\.012721513041551918\ \(0\)\
\-\ systems\\:\\ 0\\.012643042632173937\ \(0\)\
\-\ determined\\:\\ 0\\.012420082443668264\ \(0\)\
\-\ thickness\\:\\ 0\\.012280777650981184\ \(0\)\
\-\ dominant\\:\\ 0\\.012148108990843983\ \(0\)\
\-\ diseases\\:\\ 0\\.011990693363369494\ \(0\)\
\-\ lobulated\\:\\ 0\\.011960250269965063\ \(0\)\
\-\ angiography\\:\\ 0\\.011960250269965063\ \(0\)\
\-\ symptoms\\:\\ 0\\.011864387057928352\ \(0\)\
\-\ overall\\:\\ 0\\.011841699811973989\ \(0\)\
\-\ intravenous\\:\\ 0\\.011812834109925114\ \(0\)\
\-\ 3rd\\:\\ 0\\.011784264471576395\ \(0\)\
\-\ \\/\\:\\ 0\\.01175598488532565\ \(0\)\
\-\ discovered\\:\\ 0\\.011727989520831216\ \(0\)\
\-\ somewhat\\:\\ 0\\.011700272721797323\ \(0\)\
\-\ medicine\\:\\ 0\\.011290653173171983\ \(0\)\
\-\ dyspnea\\:\\ 0\\.011266946516715413\ \(0\)\
\-\ visible\\:\\ 0\\.011266946516715413\ \(0\)\
\-\ nature\\:\\ 0\\.011266946516715413\ \(0\)\
\-\ direct\\:\\ 0\\.01124343991881607\ \(0\)\
\-\ phase\\:\\ 0\\.011197013588773697\ \(0\)\
\-\ 3\\:\\ 0\\.01114749597050997\ \(0\)\
\-\ \\%\\:\\ 0\\.011104852553459653\ \(0\)\
\-\ subsequently\\:\\ 0\\.010790740950855693\ \(0\)\
\-\ disorder\\:\\ 0\\.010692993541910651\ \(0\)\
\-\ important\\:\\ 0\\.010692993541910651\ \(0\)\
\-\ contrast\\:\\ 0\\.01065613195993262\ \(0\)\
\-\ from\\:\\ 0\\.010583028243628516\ \(0\)\
\-\ apparent\\:\\ 0\\.010525252984826934\ \(0\)\
\-\ frequently\\:\\ 0\\.010316241324818816\ \(0\)\
\-\ total\\:\\ 0\\.010249916398095365\ \(0\)\
\-\ enhanced\\:\\ 0\\.010185134052233898\ \(0\)\
\-\ but\\:\\ 0\\.010153221732777369\ \(0\)\
\-\ al\\:\\ 0\\.010090700760658183\ \(0\)\
\-\ characteristic\\:\\ 0\\.010075268503344493\ \(0\)\
\-\ radiology\\:\\ 0\\.010059921272673267\ \(0\)\
\-\ diameter\\:\\ 0\\.010014380498295748\ \(0\)\
\-\ ct\\:\\ 0\\.009988609916925151\ \(0\)\
\-\ references\\:\\ 0\\.009896457479280259\ \(0\)\
\-\ nodules\\:\\ 0\\.009867740572152511\ \(0\)\
\-\ recommended\\:\\ 0\\.009867740572152511\ \(0\)\
\-\ related\\:\\ 0\\.009825212794629425\ \(0\)\
\-\ many\\:\\ 0\\.009783324556845188\ \(0\)\
\-\ appear\\:\\ 0\\.009742056908418612\ \(0\)\
\-\ et\\:\\ 0\\.009742056908418612\ \(0\)\
\-\ single\\:\\ 0\\.009648078803594516\ \(0\)\
\-\ is\\:\\ 0\\.009397617466039983\ \(0\)\
\-\ also\\:\\ 0\\.009385067374206971\ \(0\)\
\-\ similar\\:\\ 0\\.009336174426019188\ \(0\)\
\-\ cough\\:\\ 0\\.009120487127599086\ \(0\)\
\-\ \\,\\:\\ 0\\.00904880441840515\ \(0\)\
\-\ radiographic\\:\\ 0\\.009034441202754132\ \(0\)\
\-\ http\\:\\ 0\\.00901333871303698\ \(0\)\
\-\ referred\\:\\ 0\\.008981981736645241\ \(0\)\
\-\ 8\\:\\ 0\\.008900048908772558\ \(0\)\
\-\ n\\/a\\:\\ 0\\.008621745535819183\ \(0\)\
\-\ risk\\:\\ 0\\.008621745535819183\ \(0\)\
\-\ they\\:\\ 0\\.008576451605814224\ \(0\)\
\-\ typically\\:\\ 0\\.00840230019360995\ \(0\)\
\-\ or\\:\\ 0\\.008369270882705077\ \(0\)\
\-\ was\\:\\ 0\\.008258586536604625\ \(0\)\
\-\ on\\:\\ 0\\.008065638020784714\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.008046218378819185\ \(0\)\
\-\ extending\\:\\ 0\\.008002002921559323\ \(0\)\
\-\ vascular\\:\\ 0\\.007804465927364057\ \(0\)\
\-\ finding\\:\\ 0\\.007671480515427525\ \(0\)\
\-\ often\\:\\ 0\\.007594633839887611\ \(0\)\
\-\ 2\\.\\:\\ 0\\.00756948228913721\ \(0\)\
\-\ follow\\:\\ 0\\.00756322972687029\ \(0\)\
\-\ between\\:\\ 0\\.007544555811209593\ \(0\)\
\-\ enhancing\\:\\ 0\\.0074650516236344265\ \(0\)\
\-\ 1\\.\\:\\ 0\\.007435067315592203\ \(0\)\
\-\ usually\\:\\ 0\\.007228212406314092\ \(0\)\
\-\ 6\\:\\ 0\\.007108969808843661\ \(0\)\
\-\ syndrome\\:\\ 0\\.006807539210960004\ \(0\)\
\-\ abnormal\\:\\ 0\\.006788557772464934\ \(0\)\
\-\ months\\:\\ 0\\.006501229233119964\ \(0\)\
\-\ up\\:\\ 0\\.006400688443047976\ \(0\)\
\-\ these\\:\\ 0\\.006194553459492591\ \(0\)\
\-\ and\\:\\ 0\\.00601701411918279\ \(0\)\
\-\ 1\\:\\ 0\\.005663861749191384\ \(0\)\
\-\ associated\\:\\ 0\\.005616887359074379\ \(0\)\
\-\ imaging\\:\\ 0\\.005576807310461289\ \(0\)\
\-\ most\\:\\ 0\\.005495362511777371\ \(0\)\
\-\ can\\:\\ 0\\.005398948057016907\ \(0\)\
\-\ present\\:\\ 0\\.005376068952455936\ \(0\)\
\-\ 2\\:\\ 0\\.00512563926604609\ \(0\)\
\-\ findings\\:\\ 0\\.005066398149832757\ \(0\)\
\-\ right\\:\\ 0\\.005023017878052461\ \(0\)\
\-\ multiple\\:\\ 0\\.005013387196321083\ \(0\)\
\-\ surgical\\:\\ 0\\.0050034032597533525\ \(0\)\
\-\ lesion\\:\\ 0\\.00484834324791213\ \(0\)\
\-\ patient\\:\\ 0\\.0047720998936846126\ \(0\)\
\-\ seen\\:\\ 0\\.004703698092110558\ \(0\)\
\-\ for\\:\\ 0\\.004061883836449666\ \(0\)\
\-\ as\\:\\ 0\\.0036004944453875425\ \(0\)\
\-\ the\\:\\ 0\\.003465859505104825\ \(0\)\
\-\ a\\:\\ 0\\.003314204472021738\ \(0\)\
\-\ with\\:\\ 0\\.0026073354003318047\ \(0\)\
\-\ \\.\\:\\ 0\\.002373228039934013\ \(0\)\
\-\ in\\:\\ 0\\.0023476168810042056\ \(0\)\
\-\ of\\:\\ 0\\.0016226156099998388\ \(0\)\
